Health Care & Life Sciences » Pharmaceuticals | Siegfried Holding AG

Siegfried Holding AG | Balance Sheet

Fiscal year is January-December. All values CHF Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
128
50
47
32
34
40
Total Accounts Receivable
62
69
124
156
189
221
Inventories
99
123
257
244
248
228
Other Current Assets
8
31
34
36
41
45
Total Current Assets
297
273
462
468
514
534
Net Property, Plant & Equipment
208
315
470
488
500
521
Total Investments and Advances
1
1
4
3
1
-
Intangible Assets
10
9
10
9
9
11
Other Assets
8
9
9
10
13
9
Total Assets
538
630
1,004
1,021
1,069
1,103
ST Debt & Current Portion LT Debt
17
22
10
-
-
Accounts Payable
31
44
65
55
71
Income Tax Payable
-
-
3
2
5
Other Current Liabilities
50
41
70
66
72
Total Current Liabilities
99
107
148
124
148
Long-Term Debt
60
113
372
407
356
Provision for Risks & Charges
11
9
141
139
139
Deferred Taxes
9
18
43
38
25
Other Liabilities
2
13
2
2
1
Total Liabilities
175
247
669
677
651
Common Equity (Total)
362
383
335
345
417
Total Shareholders' Equity
362
383
335
345
417
Total Equity
362
383
335
345
417
Liabilities & Shareholders' Equity
538
630
1,004
1,021
1,069

About Siegfried Holding

View Profile
Address
Untere Brühlstrasse 4
Zofingen Aargau (Argovia) 4800
Switzerland
Employees -
Website http://www.siegfried.ch
Updated 07/08/2019
Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. It also provides development and production services for finished dosage forms including sterile filling. The company was founded by Samuel Benoni Siegfried in 1873 and is headquartered in Zofingen, Switzerland.